PRECISION BIOSCIENCES INC (DTIL) Net Income (Loss) Attributable to Parent USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Precision Biosciences Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to 2024.
  • Precision Biosciences Inc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was $8.59 M.
  • Precision Biosciences Inc Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$27.7 M, a 74.5% increase year-over-year.
  • Precision Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$61.3 M, a 45.1% increase from 2022.
  • Precision Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$112 M, a 265% decline from 2021.
  • Precision Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$30.6 M, a 71.9% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$27.7 M $8.59 M +$33.6 M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$61.3 M -$16.3 M +$12.2 M +42.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$73.5 M -$8.08 M +$15.9 M +66.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$89.4 M -$11.9 M +$19.1 M +61.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-07
Q1 2023 -$109 M -$25.1 M +$3.11 M +11% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$112 M -$28.5 M -$6.2 M -27.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$105 M -$23.9 M -$12.7 M -112% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$92.8 M -$31 M -$52.7 M -243% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$40.1 M -$28.2 M -$9.48 M -50.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$30.6 M -$22.3 M +$1.16 M +4.96% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$31.8 M -$11.3 M +$14.7 M +56.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$46.5 M $21.7 M +$54.4 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$101 M -$18.7 M +$8.15 M +30.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$109 M -$23.5 M -$2.54 M -12.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$106 M -$26 M -$5.27 M -25.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$101 M -$32.7 M -$13.3 M -68.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$87.9 M -$26.8 M +$4.95 M +15.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$92.9 M -$20.9 M -$5.47 M -35.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 -$87.4 M -$20.7 M -$11 M -113% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$76.4 M -$19.4 M -$7.61 M -64.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-10
Q1 2019 -$68.8 M -$31.8 M -$22.8 M -253% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-10
Q4 2018 -$46 M -$15.4 M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$9.76 M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$11.8 M Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-12
Q1 2018 -$9.01 M Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.